Vaccine candidate discovery for the next generation of malaria vaccines. by Tuju, J, Kamuyu, G, Murungi, LM, Osier, FHA

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria by Murungi, L, Kamuyu, G, Lowe, B, Bejon, P, Theisen, M, Kinyanjui, S, Marsh, K, Osier, F

A threshold concentration of anti-merozoite antibodies is required for protection from clinical episodes of malaria. by Murungi, L, Kamuyu, G, Lowe, B, Bejon, P, Theisen, M, Kinyanjui, S, Marsh, K, Osier, F

Analysis of antibodies to newly described Plasmodium falciparum merozoite antigens supports MSPDBL2 as a predicted target of naturally acquired immunity. by Tetteh, K, Osier, F, Salanti, A, Kamuyu, G, Drought, L, Failly, M, Martin, C, Marsh, K, Conway, D

The ratio of monocytes to lymphocytes in peripheral blood correlates with increased susceptibility to clinical malaria in Kenyan children. by Warimwe, G, Murungi, L, Kamuyu, G, Nyangweso, G, Wambua, J, Naranbhai, V, Fletcher, H, Hill, A, Bejon, P, Osier, F, Marsh, K

Prevalence and risk factors for active convulsive epilepsy in rural northeast South Africa by Wagner, R, Ngugi, A, Twine, R, Bottomley, C, Kamuyu, G, Gómez-Olivé, F, Connor, MD, Collinson, M, Kahn, K, Tollman, S, Newton, C

Prevalence and risk factors for active convulsive epilepsy in rural northeast South Africa. by Wagner, R, Ngugi, A, Twine, R, Bottomley, C, Kamuyu, G, Gómez-Olivé, F, Connor, MD, Collinson, M, Kahn, K, Tollman, S, Newton, C

New antigens for a multicomponent blood-stage malaria vaccine. by Osier, F, Mackinnon, M, Crosnier, C, Fegan, G, Kamuyu, G, Wanaguru, M, Ogada, E, McDade, B, Rayner, J, Wright, G, Marsh, K

protGear: A protein microarray data pre-processing suite by Mwai, K, Kibinge, N, Tuju, J, Kamuyu, G, Kimathi, R, Mburu, J, Chepsat, E, Nyamako, L, Chege, T, Nkumama, I, Kinyanjui, S, Musenge, E, Osier, F

Plasmodium falciparum Merozoite Associated Armadillo Protein (PfMAAP) is apically localized in free merozoites and antibodies are associated with reduced risk of malaria by Aniweh, Y, Nyarko, PB, Charles-Chess, E, Ansah, F, Osier, FHA, Quansah, E, Thiam, LG, Kamuyu, G, Marsh, K, Conway, DJ, Tetteh, KKA, Awandare, GA

Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural ex... by Abdi, A, Hodgson, S, Muthui, M, Kivisi, C, Kamuyu, G, Kimani, D, Hoffman, S, Juma, E, Ogutu, B, Draper, S, Osier, F, Bejon, P, Marsh, K, Bull, P

Exposure to parasitic infections determines features and phenotypes of active convulsive epilepsy in Africa by Langat, NK, Kariuki, SM, Kamuyu, G, Kakooza-Mwesige, A, Owusu-Agyei, S, Ae-Ngibise, K, Wang'ombe, A, Ngugi, AK, Masaja, H, Wagner, RG, Newton, CRJC

Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: cross-sectional and case-control studies. by Ngugi, A, Bottomley, C, Kleinschmidt, I, Wagner, R, Kakooza-Mwesige, A, Ae-Ngibise, K, Owusu-Agyei, S, Masanja, H, Kamuyu, G, Odhiambo, R, Chengo, E, Sander, J, Newton, C

Prevalence of active convulsive epilepsy in sub-Saharan Africa and associated risk factors: Cross-sectional and case-control studies by Ngugi, A, Bottomley, C, Kleinschmidt, I, Wagner, R, Kakooza-Mwesige, A, Ae-Ngibise, K, Owusu-Agyei, S, Masanja, H, Kamuyu, G, Odhiambo, R, Chengo, E, Sander, J, Newton, C

Binding of Plasmodium falciparum merozoite surface proteins DBLMSP and DBLMSP2 to human immunoglobulin M is conserved amongst broadly diverged sequence variants by Crosnier, C, Iqbal, Z, Knuepfer, E, Maciuca, S, Perrin, A, Kamuyu, G, Goulding, D, Bustamante, L, Miles, A, Moore, S, Dougan, G, Holder, A, Kwiatkowski, D, Rayner, J, Pleass, R, Wright, G

Binding of Plasmodium falciparum merozoite surface proteins DBLMSP and DBLMSP2 to human immunoglobulin M Is conserved among broadly diverged sequence variants by Crosnier, C, Iqbal, Z, Knuepfer, E, Maciuca, S, Perrin, A, Kamuyu, G, Goulding, D, Bustamante, L, Miles, A, Moore, S, Dougan, G, Holder, A, Kwiatkowski, D, Rayner, J, Pleass, R, Wright, G

The blood-stage malaria antigen PfRH5 is susceptible to vaccine-inducible cross-strain neutralizing antibody. by Douglas, A, Williams, A, Illingworth, J, Kamuyu, G, Biswas, S, Goodman, A, Wyllie, D, Crosnier, C, Miura, K, Wright, G, Long, C, Osier, F, Marsh, K, Turner, A, Hill, A, Draper, S

Distinct kinetics of antibodies to 111 Plasmodium falciparum proteins identifies markers of recent malaria exposure by Yman, V, Tuju, J, White, MT, Kamuyu, G, Mwai, K, Kibinge, N, Asghar, M, Sundling, C, Sondén, K, Murungi, L, Kiboi, D, Kimathi, R, Chege, T, Chepsat, E, Kiyuka, P, Nyamako, L, Osier, FHA, Färnert, A

Exposure to multiple parasites is associated with the prevalence of active convulsive epilepsy in sub-Saharan Africa by Kamuyu, G, Bottomley, C, Mageto, J, Lowe, B, Wilkins, P, Noh, J, Nutman, T, Ngugi, A, Odhiambo, R, Wagner, R, Kakooza-Mwesige, A, Owusu-Agyei, S, Ae-Ngibise, K, Masanja, H, Osier, F, Odermatt, P, Newton, C

Changes in serological immunology measures in UK and Kenyan adults post-controlled human malaria infection by Hodgson, S, Llewellyn, D, Silk, S, Milne, K, Elias, S, Miura, K, Kamuyu, G, Juma, E, Magiri, C, Muia, A, Jin, J, Spencer, A, Longley, R, Mercier, T, Decosterd, L, Long, C, Osier, F, Hoffman, S, Ogutu, B, Hill, A, Marsh, K, Draper, S